ZymoGenetics Inc. (Nasdaq: ZGEN) reports Q1 loss of $0.26, 6 cents better than the analyst estimate of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE